Nextstep Innovation
The computed 12-month bankruptcy probability of Nextstep Innovation is 0.4% (very low). The 2024 annual accounts show equity of €83k and a net result of €81k. Its solvency ranks better than 66% of 12451 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €83k |
| Net result | €81k |
| Better than sector | 66% |
| Active | 2 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 71.3% | 60.6% | |
| Net result | €81k | €31k | |
| Equity | €83k | €63k | |
| Gross operating margin | €99k | €52k | |
| Total assets | €116k | €124k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €99k |
| Net profit | €81k |
| Cash flow | €81k |
| Staff costs | - |
| Income taxes | €21k |
| Dividends | €2k |
| Total assets | €116k |
| Equity | €83k |
| Debt | €33k |
| of which ≤ 1y | €32k |
| of which > 1y | - |
| Working capital | €82k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 3.56 |
| Quick ratio | 3.56 |
| Working capital ratio | 70.9% |
| Solvency | 71.3% |
| Debt / equity | 0.40 |
| Long-term debt ratio | - |
| Interest coverage | 76.12 |
| Gross margin | - |
| Net margin | - |
| ROA | 69.7% |
| ROE | 97.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €116k |
| Fixed assets | 21/28 | €2k |
| Tangible fixed assets | 22/27 | €933 |
| Financial fixed assets | 28 | €750 |
| Current assets | 29/58 | €114k |
| Amounts receivable within one year | 40/41 | €61k |
| Cash & bank | 54/58 | €41k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €116k |
| Equity | 10/15 | €83k |
| Contributions / capital | 10/11 | €4k |
| Reserves | 13 | €79k |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €33k |
| Amounts payable within one year | 42/48 | €32k |
| Trade debts payable within one year | 44 | €113 |
| Income statement | ||
| Gross operating margin | 9900 | €99k |
| Operating result | 9901 | €99k |
| Financial income | 75 | €4k |
| Financial charges | 65 | €1k |
| Result before taxes | 9903 | €102k |
| Income taxes | 67/77 | €21k |
| Net result for the period | 9904 | €81k |
| Result to be appropriated | 9905 | €81k |
-
Current01-07-2026 → present
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 21-12-2023 |
| Status | Active |
| Postal code | 8400 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 35020B0467/00E011 | Flanders | 320 m² | 1 · 110 m² | 11.5 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
04-08-2026 General meeting · Officer appointment · Power of attorney
- Publication: 04/08/2026 · Nextstep Innovation
- Filing: 27/07/2026 · Nextstep Innovation
- General meeting: 01/07/2026 · Nextstep Innovation
- Officer appointment: role: bestuurder, start_date: 2026-07-01 · Lahbabi Soukaïna
- Power of attorney: scope: alle stukken en akten te tekenen, inclusief de neerlegging te doen van alle benodigde documenten en formulieren jegens de bevoegde instanities en de ondernemingsrechtbank, substitute: Lagaert Carolina · BV DECOSTERE ACCOUNTANCY DRONGEN
Technical details
{
"facts": [
{
"date": "2026-08-04",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 04/08/2026",
"value": "04/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-27",
"type": "filing",
"quote": "NEERLEGGING TER GRIFFIE ... 27 JULI 2026",
"value": "27/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-01",
"type": "general_meeting",
"quote": "Op de buitengewone algemene vergadering van 01/07/2026",
"value": "01/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-01",
"type": "officer_appointment",
"quote": "De benoeming van de bestuurder: Lahbabi Souka\u00EFna ... met ingang van 01/07/2026",
"value": {
"role": "bestuurder",
"start_date": "2026-07-01"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "01/07/2026"
}
},
{
"type": "power_of_attorney",
"quote": "Dat er in dit kader een bijzondere volmacht verleend werd aan BV DECOSTERE ACCOUNTANCY DRONGEN ... en meer specifiek aan mevrouw Lagaert Carolina",
"value": {
"scope": "alle stukken en akten te tekenen, inclusief de neerlegging te doen van alle benodigde documenten en formulieren jegens de bevoegde instanities en de ondernemingsrechtbank",
"substitute": "Lagaert Carolina"
},
"object": "e1",
"subject": "e3"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1567,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "1003.744.617",
"kind": "company",
"name": "Nextstep Innovation",
"attrs": {
"seat": "8400 Oostende - Sint-Jansstraat 29",
"legal_form": "Besloten Vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Lahbabi Souka\u00EFna",
"attrs": {
"address": "8400 Oostende, Sit-Jansstraat 29"
}
},
{
"id": "e3",
"kbo": "0460.289.348",
"kind": "company",
"name": "BV DECOSTERE ACCOUNTANCY DRONGEN",
"attrs": {
"seat": "9031 Drongen, Deinsesteenweg 108"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Lagaert Carolina",
"attrs": {
"address": null
}
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Nextstep Innovation |